<p>|Recommendation|Level of evidence|PICO|
|---|---|---|
|1. We strongly recommend treatment with NSAIDs over no treatment with NSAIDs.†|Low|2|
|2. We conditionally recommend continuous treatment with NSAIDs over on-demand treatment with NSAIDs.|Low to moderate|1|
|3. We do not recommend any particular NSAID as the preferred choice.†|Low to moderate|3|
|4. In adults with active AS despite treatment with NSAIDs, we conditionally recommend treatment with sulfasalazine, methotrexate, or tofacitinib over no treatment with these medications. Sulfasalazine or methotrexate should be considered only in patients with prominent peripheral arthritis or when TNFi are not available.|Very low to moderate|7|
|5. In adults with active AS despite treatment with NSAIDs, we conditionally recommend treatment with TNFi over treatment with tofacitinib.|Very low|60|
|6. In adults with active AS despite treatment with NSAIDs, we strongly recommend treatment with TNFi over no treatment with TNFi.|High|6|